Guardian Pharmacy Services, Inc. officer David Martin filed a Form 144 notice of proposed sale on November 17, 2026, disclosing plans to sell 20,000 shares of common stock through Morgan Stanley Smith Barney LLC.

Key Highlights

  • Proposed seller: David Martin, identified as an officer of Guardian Pharmacy Services, Inc.
  • Shares proposed for sale: 20,000 shares of common stock, with an aggregate market value of $988,600.00.
  • Shares outstanding: 63,320,300 shares of common stock reported outstanding.
  • Acquisition date: The 20,000 shares were acquired on September 26, 2024, via an M&A transaction from the issuer.
  • Approximate sale date: November 17, 2026, through broker Morgan Stanley Smith Barney LLC.
  • Rule 10b5-1 plan: The notice indicates a trading plan or instruction date of August 18, 2026.
  • Prior three-month sales: The filing reports nothing to disclose for securities sold in the past three months.

David Martin's Proposed Sale Under Rule 144 at Guardian Pharmacy Services

According to the filing, David Martin, an officer of Guardian Pharmacy Services, Inc. (NYSE:GRDN), submitted a Form 144 notice dated November 17, 2026, disclosing a proposed sale of 20,000 shares of the company's common stock. The aggregate market value of the shares proposed to be sold is listed as $988,600.00. The filing identifies Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as the named broker for the transaction.

The filing states that the 20,000 shares were acquired on September 26, 2024, through an M&A transaction from the issuer, with the date of payment also listed as September 26, 2024. The nature of payment is listed as "N/A." According to the filing, the total number of shares of common stock outstanding is 63,320,300. The notice reports no securities of the issuer sold during the past three months by the person for whose account the securities are to be sold.

The filing notes a plan adoption or instruction date of August 18, 2026, indicating reliance on Rule 10b5-1 under the Exchange Act. By signing the form, the filer represented, as of that plan adoption date, that he did not know of any material adverse information regarding the current and prospective operations of the issuer that had not been publicly disclosed, as required by the form's attestation language.

What Was Disclosed

Guardian Pharmacy Services officer David Martin filed a Form 144 proposing to sell 20,000 shares of common stock with an aggregate market value of $988,600.00, acquired via an M&A transaction in September 2024, with an approximate sale date of November 17, 2026, under a Rule 10b5-1 plan adopted August 18, 2026.